Found: 231
Select item for more details and to access through your institution.
The Clinical Spectrum of Guam ALS and Parkinson-Dementia Complex: 1997-1999.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 920, n. 1, p. 120, doi. 10.1111/j.1749-6632.2000.tb06913.x
- By:
- Publication type:
- Article
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Arguing against the proposed definition changes of PD.
- Published in:
- 2016
- By:
- Publication type:
- journal article
CSF Aβ<sub>42</sub> and tau in Parkinson's disease with cognitive impairment.
- Published in:
- Movement Disorders, 2010, v. 25, n. 15, p. 2682, doi. 10.1002/mds.23287
- By:
- Publication type:
- Article
Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease.
- Published in:
- Movement Disorders, 2006, v. 21, n. 3, p. 337, doi. 10.1002/mds.20726
- By:
- Publication type:
- Article
Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer's Disease before Symptom Onset.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 3, p. 207, doi. 10.3390/cells13030207
- By:
- Publication type:
- Article
NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3514, doi. 10.3390/cells10123514
- By:
- Publication type:
- Article
Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01106-4
- By:
- Publication type:
- Article
Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00851-2
- By:
- Publication type:
- Article
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Primary Care Screening for Dementia and Mild Cognitive Impairment.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.
- Published in:
- Human Molecular Genetics, 2009, v. 18, n. 19, p. 3725, doi. 10.1093/hmg/ddp300
- By:
- Publication type:
- Article
Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.
- Published in:
- Human Molecular Genetics, 2007, v. 16, n. 3, p. 295, doi. 10.1093/hmg/ddl463
- By:
- Publication type:
- Article
Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches.
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00256
- By:
- Publication type:
- Article
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0281-7
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0271-9
- By:
- Publication type:
- Article
Modulation of Aβ42 in vivo by ?-secretase modulator in primates and humans.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0137-y
- By:
- Publication type:
- Article
Recent Alzheimer's disease research highlights.
- Published in:
- Alzheimer's Research & Therapy, 2012, v. 4, n. 3, p. 1, doi. 10.1186/alzrt117
- By:
- Publication type:
- Article
Right sizing funding for Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0257372
- By:
- Publication type:
- Article
Lewy bodies and dementia.
- Published in:
- Current Neurology & Neuroscience Reports, 2001, v. 1, n. 5, p. 435, doi. 10.1007/s11910-001-0103-x
- By:
- Publication type:
- Article
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 1152, doi. 10.1093/brain/awac407
- By:
- Publication type:
- Article
Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 4, p. 618, doi. 10.1002/ana.26768
- By:
- Publication type:
- Article
TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 1, p. 31, doi. 10.1007/s00401-023-02574-0
- By:
- Publication type:
- Article
Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 4, p. 789, doi. 10.1007/s00401-022-02480-x
- By:
- Publication type:
- Article
Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.
- Published in:
- Acta Neuropathologica, 2022, v. 143, n. 4, p. 487, doi. 10.1007/s00401-022-02408-5
- By:
- Publication type:
- Article
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 1, p. 63, doi. 10.1007/s00401-019-02080-2
- By:
- Publication type:
- Article
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 6, p. 935, doi. 10.1007/s00401-016-1552-2
- By:
- Publication type:
- Article
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.
- Published in:
- Acta Neuropathologica, 2014, v. 128, n. 5, p. 639, doi. 10.1007/s00401-014-1314-y
- By:
- Publication type:
- Article
Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam.
- Published in:
- Acta Neuropathologica, 2008, v. 115, n. 1, p. 133, doi. 10.1007/s00401-007-0257-y
- By:
- Publication type:
- Article
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
- Published in:
- Acta Neuropathologica, 2007, v. 114, n. 3, p. 221, doi. 10.1007/s00401-007-0261-2
- By:
- Publication type:
- Article
Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
- Published in:
- Acta Neuropathologica, 2006, v. 111, n. 5, p. 401, doi. 10.1007/s00401-006-0053-0
- By:
- Publication type:
- Article
The ageing systemic milieu negatively regulates neurogenesis and cognitive function.
- Published in:
- Nature, 2011, v. 477, n. 7362, p. 90, doi. 10.1038/nature10357
- By:
- Publication type:
- Article
A rapid α‐synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 2, p. 374, doi. 10.1002/acn3.51280
- By:
- Publication type:
- Article
Tau oligomers in cerebrospinal fluid in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 4, p. 226, doi. 10.1002/acn3.382
- By:
- Publication type:
- Article
Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2010, v. 5, p. 1, doi. 10.1186/1750-1326-5-2
- By:
- Publication type:
- Article
The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments.
- Published in:
- Journal of Neurochemistry, 1997, v. 68, n. 1, p. 430, doi. 10.1046/j.1471-4159.1997.68010430.x
- By:
- Publication type:
- Article
Comparison of the Memory Performance Index With Standard Neuropsychological Measures of Cognition.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Effects of Apolipoprotein E-ε4 and ε-2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 3, p. 233, doi. 10.1177/1533317509357736
- By:
- Publication type:
- Article
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12375
- By:
- Publication type:
- Article
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 871, doi. 10.1016/j.trci.2019.11.002
- By:
- Publication type:
- Article
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 11, doi. 10.1016/j.trci.2017.11.001
- By:
- Publication type:
- Article